Reveal Pharmaceuticals, Inc.
Cambridge, MA
- UEI
- LAS2A8MTAR45
- CAGE
- 7PBF3
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 37 Prentiss St, Cambridge, MA 02140, USA
- Website
- revealpharma.com
- Founded
- 2016
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Reveal Pharmaceuticals In, doing business as Reveal Pharma, is a biotechnology company specializing in developing gadolinium-free MRI contrast agents for precision imaging to provide deeper insight into medical conditions. Through past federal grants, Reveal Pharma has conducted research and development related to manganese-based MRI contrast agents as potential alternatives to gadolinium-based contrast agents.
Specifically, Reveal Pharma has received federal grants from the National Institutes of Health to support clinical trials and continued development of its lead product RVP-001. These include multiple National Cancer Institute grants funding studies related to evaluating RVP-001's efficacy in cancer imaging, as well as a National Institute of Diabetes and Digestive and Kidney Diseases grant to develop an MRI contrast agent to detect liver fibrosis. Additional grants have come from the National Heart, Lung, and Blood Institute to demonstrate RVP-001's utility in cardiac imaging. Across these awards, Reveal Pharma has provided scientific and technical capabilities related to the development and testing of manganese-based contrast agents, with the goal of establishing safety, efficacy, and imaging equivalence or superiority to standard gadolinium-based agents across multiple medical imaging applications.
Quick answers
Is Reveal Pharmaceuticals, Inc. registered in SAM.gov?
Yes. Reveal Pharmaceuticals, Inc.'s SAM.gov registration is active through December 16, 2026.
What is Reveal Pharmaceuticals, Inc.'s most recent federal award?
Reveal Pharmaceuticals, Inc.'s most recent federal grant award is Manganese based MRI contrast agent - gadolinium (GD)-based MRI contrast agents (gbcas) are used in clinical magnetic… (R44CA261240), from National Cancer Institute (NIH), on June 5, 2023.
On GovTribe
See Reveal Pharmaceuticals, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors